APDUCE

Serial Number 97412748
Registration 7172959
700

Registration Progress

Application Filed
May 16, 2022
Under Examination
Approved for Publication
Jul 11, 2023
Published for Opposition
Jul 11, 2023
Registered
Sep 26, 2023

Trademark Image

APDUCE

Basic Information

Serial Number
97412748
Registration Number
7172959
Filing Date
May 16, 2022
Registration Date
September 26, 2023
Published for Opposition
July 11, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Sep 26, 2023
Registration
Registered
Classes
005

Rights Holder

ASCENTAGE PHARMA (SUZHOU) CO., LTD.

03
Address
68 XINQING ROAD
SUZHOU INDUSTRIAL PARK, SUZHOU
JIANGSU 215000
CN

Ownership History

ASCENTAGE PHARMA (SUZHOU) CO., LTD.

Original Applicant
03
JIANGSU CN

ASCENTAGE PHARMA (SUZHOU) CO., LTD.

Owner at Publication
03
JIANGSU CN

ASCENTAGE PHARMA (SUZHOU) CO., LTD.

Original Registrant
03
JIANGSU CN

Legal Representation

Attorney
Kathryn E. Smith

USPTO Deadlines

Next Deadline
1519 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-09-26)
Due Date
September 26, 2029
Grace Period Ends
March 26, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

23 events
Date Code Type Description Documents
Sep 26, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Sep 26, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jul 11, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 11, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 21, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 5, 2023 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
May 27, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
May 27, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
May 27, 2023 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
May 27, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 27, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Apr 24, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 24, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Apr 24, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 12, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 12, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Mar 12, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 3, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 27, 2022 ALIE A ASSIGNED TO LIE Loading...
Jun 27, 2022 AMPX O PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Loading...
Jun 14, 2022 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
May 23, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 19, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Chemical preparations for medical purposes, for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; drugs sold in bulk, for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; biochemical medicines for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; medicines for human purposes for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; chemico-pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; drugs for medical purposes in the nature of prescription apoptosis targeted compounds, next-generation kinase inhibitors and senolytic drugs; biological preparations for medical purposes, namely, biological preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; chemical preparations for pharmaceutical purposes, namely, for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; radioactive substances for medical purposes; gases for medical purposes, namely, nitric oxide for medical purposes; chemical conductors for electrocardiograph electrodes; semen for artificial insemination; disinfectants; solutions for contact lenses; media for bacteriological cultures; medicated sweets; dietetic preparations adapted for medical use; depuratives for the body; diagnostic preparations for veterinary purposes; pesticides; sanitary napkins; cotton for medical purposes; dental abrasives; diapers for pets

Classification

International Classes
005